Literature DB >> 8334679

Cytotoxic activity and T cell receptor repertoire in tumor-infiltrating lymphocytes of adrenal cell carcinomas.

Y Yamamoto1, K Backlin, H Nakagomi, E Halapi, C Juhlin, A Bucht, R Kiessling.   

Abstract

The cytotoxic activity and T cell receptor (TCR) V beta repertoire in tumor-infiltrating lymphocytes (TIL) of three primary adrenal cell carcinomas were analyzed. Fresh, non-cultured TIL from two of the three tumors showed low but significant lysis of the autologous tumor, and for one of the patients this activity was strongly enhanced upon culture in interleukin-2. An allogeneic adrenal cell carcinoma line and the K562 or Daudi targets included as controls were not killed. Phenotypic analysis of freshly isolated TIL demonstrated that the cells from the two patients that demonstrated cytolytic capacity mainly consisted of CD45RO+ T cells. In vitro cultured TIL lines from these patients demonstrated a high percentage of CD8+ cells expressing either the V beta 6 gene or the V beta 8 gene product, as measured with a panel of mAb specific for TCR V alpha and V beta gene products. Analysis of the TCR V beta gene mRNA expression in freshly isolated non-cultured TIL, using a polymerase-chain-reaction-assisted cDNA-amplification assay, confirmed the strong expression of the genes coding for the TCR V beta 6 or the V beta 8. This assay also demonstrated a more restricted TCR V beta gene usage in the TIL as compared to peripheral blood lymphocytes from the same patient.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8334679     DOI: 10.1007/bf01525430

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  25 in total

1.  Biased expression of individual T cell receptor V gene segments in CD4+ and CD8+ human peripheral blood T lymphocytes.

Authors:  J Grunewald; C H Janson; H Wigzell
Journal:  Eur J Immunol       Date:  1991-03       Impact factor: 5.532

Review 2.  The synergy between naive and memory T cells during activation.

Authors:  A N Akbar; M Salmon; G Janossy
Journal:  Immunol Today       Date:  1991-06

3.  Interaction of Staphylococcus aureus toxin "superantigens" with human T cells.

Authors:  Y W Choi; B Kotzin; L Herron; J Callahan; P Marrack; J Kappler
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

4.  Induction by interleukin-2 of oligoclonal expansion of cultured tumor-infiltrating lymphocytes.

Authors:  A J Fishleder; J H Finke; R Tubbs; R M Bukowski
Journal:  J Natl Cancer Inst       Date:  1990-01-17       Impact factor: 13.506

5.  Restricted T cell receptor V-beta and J-beta usage in T cells from interleukin-2-cultured lymphocytes of ovarian and renal carcinomas.

Authors:  E Halapi; Y Yamamoto; C Juhlin; M Jeddi-Tehrani; J Grunewald; R Andersson; C Hising; G Masucci; H Mellstedt; R Kiessling
Journal:  Cancer Immunol Immunother       Date:  1993       Impact factor: 6.968

6.  Depression of natural killer cytotoxic activity in lymphocytes infiltrating human pulmonary tumors.

Authors:  P M Moy; E C Holmes; S H Golub
Journal:  Cancer Res       Date:  1985-01       Impact factor: 12.701

7.  Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy.

Authors:  J P Luton; S Cerdas; L Billaud; G Thomas; B Guilhaume; X Bertagna; M H Laudat; A Louvel; Y Chapuis; P Blondeau
Journal:  N Engl J Med       Date:  1990-04-26       Impact factor: 91.245

8.  Immunotherapy of patients with advanced cancer using tumor-infiltrating lymphocytes and recombinant interleukin-2: a pilot study.

Authors:  S L Topalian; D Solomon; F P Avis; A E Chang; D L Freerksen; W M Linehan; M T Lotze; C N Robertson; C A Seipp; P Simon
Journal:  J Clin Oncol       Date:  1988-05       Impact factor: 44.544

9.  Dominant rearrangements among human tumor-infiltrating lymphocytes. Analysis of T-cells derived from 32 patients with melanoma, lung, and renal cell carcinoma.

Authors:  W T Bennett; F Pandolfi; B H Grove; G E Hawes; L A Boyle; R L Kradin; J T Kurnick
Journal:  Cancer       Date:  1992-05-01       Impact factor: 6.860

10.  A phase II study of interleukin-2 and lymphokine-activated killer cells in patients with metastatic malignant melanoma.

Authors:  J P Dutcher; S Creekmore; G R Weiss; K Margolin; A B Markowitz; M Roper; D Parkinson; N Ciobanu; R I Fisher; D H Boldt
Journal:  J Clin Oncol       Date:  1989-04       Impact factor: 44.544

View more
  6 in total

Review 1.  T cell receptor usage in malignant diseases.

Authors:  E Halapi; M Jeddi-Tehrani; A Osterborg; H Mellstedt
Journal:  Springer Semin Immunopathol       Date:  1999

2.  Tumor-infiltrating memory T-lymphocytes for prognostic prediction in cancer patients: a meta-analysis.

Authors:  Qingzhu Jia; Yi Yang; Ying Wan
Journal:  Int J Clin Exp Med       Date:  2015-02-15

3.  Vbeta4(+) T cells promote clearance of infection in murine pulmonary histoplasmosis.

Authors:  F J Gomez; J A Cain; R Gibbons; R Allendoerfer; G S Deepe
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

Review 4.  Oligoclonal T cells in human cancer.

Authors:  E Halapi
Journal:  Med Oncol       Date:  1998-12       Impact factor: 3.064

5.  Analysis of T cell receptor variability in fresh tumor-infiltrating lymphocytes from human head and neck cancer.

Authors:  K Chikamatsu; M Eura; K Nakano; Y Kanzaki; H Matsuoka; K Masuyama; T Ishikawa
Journal:  Jpn J Cancer Res       Date:  1994-06

6.  Sensitive detection of EBV microRNAs across cancer spectrum reveals association with decreased survival in adult acute myelocytic leukemia.

Authors:  Mercedeh Movassagh; Cliff Oduor; Catherine Forconi; Ann M Moormann; Jeffrey A Bailey
Journal:  Sci Rep       Date:  2019-12-30       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.